CrestecBio｜News

News

CrestecBio Raises Funds through J-KISS Type Stock Acquisition Rights

Bynews

5月 9, 2023

CrestecBio Inc. (Head office: Tsukuba, Ibaraki Prefecture, Japan; CEO: Aiki Marushima) has raised funds through the issuance of J-KISS type stock acquisition rights to Newsight Tech Angels, Inc.

By news

Related Post

News

Our CEO, Dr. Marushima, presented at the JHVS AMED Seeds Acceleration Pitch 2025.

10月 8, 2025 news_en
News

Our CEO, Dr. Marushima, presented at University of Tsukuba Night 2025 held in Boston.

9月 8, 2025 news_en
News

Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.

5月 25, 2025 news_en

見逃しています

News

Our CEO, Dr. Marushima, presented at the JHVS AMED Seeds Acceleration Pitch 2025.

2025-10-08 news_en
News

Our CEO, Dr. Marushima, presented at University of Tsukuba Night 2025 held in Boston.

2025-09-08 news_en
News

Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.

2025-05-25 news_en
News

Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.

2025-05-16 news_en